Pharmos(PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: NeuroInvestment who wrote (931)	6/28/1998 11:21:00 AM
From: Ariella	of 1491

Just for the record--the Israeli Consulate passes along this info: << The international French concern Rhone Poulence is expanding its activities in Israel in the field of pharmaceuticals, and will invest millions of shekels in development and clinical research, GLOBES reported. The company's Israeli activities amounted to $35 million in 1997. It's involvement in the drug field focuses on the development of ethic drugs, and its main expertise lies in oncologic drugs and drugs for blood coagulation, allergies and asthma.>> No precise connection to PARS, but another indication of how many big pharmaceuticals are coming to Israel for its expertise in R&D.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next